The European Commission has cleared Sanofi's 6-in-1 pediatric vaccine for infants starting at six weeks. The vaccine prevents hepatitis B, poliomyelitis, diphtheria, tetanus, pertussis and invasive infections caused by Haemophilus influenzae type B. The vaccine will be sold as Hexyon in Western Europe and as Hexacima in Eastern Europe.
EU approves Sanofi's 6-in-1 vaccine for infants
SmartBrief Job Listings for Health Care
|Vice President of Regulatory Affairs||
|Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX||
|Santa Clara, CA|
|Senior Director, Biostatistics||